10:17 AM EST - Valeant Pharmaceuticals International, Inc. : announced that effective March 10, the company completed its previously announced acquisition of PharmaSwiss S.A. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading down $0.17 at $38.13.
